Guideline-concordant timely lung cancer care and prognosis among elderly patients in the United States: A population-based study

Cancer Epidemiology

Volumn 39, Issue 6, 2015, Pages 1136-1144

  Nadpara, Pramit ^a   Madhavan, S Suresh ^b   Tworek, Cindy ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Cancer; Disparities; Elderly; Guidelines; Lung; Medicare; Treatment

Indexed keywords

AGE; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY ASSESSMENT; EARLY CANCER; FEMALE; HEALTH CARE QUALITY; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; LOWEST INCOME GROUP; LUNG CANCER; MALE; MEDICARE; MENTAL STRESS; PATIENT CARE; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE; RISK ASSESSMENT; UNITED STATES; CANCER REGISTRY; CARCINOMA, NON-SMALL-CELL LUNG; LUNG NEOPLASMS; MORTALITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTOCOL COMPLIANCE; STATISTICS AND NUMERICAL DATA; TIME TO TREATMENT;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GUIDELINE ADHERENCE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; TIME-TO-TREATMENT; UNITED STATES;

EID: 84951567785     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2015.06.005     Document Type: Article

References (34)

1. U.S.National Institutes of Health SEER Cancer Statistics Review, 1973-2008 2015, National Cancer Institute, Available at: http://seer.cancer.gov/csr/1975_2009_pops09/index.html (accessed January 14.01.15).
2. Day J.C. Population Projections of the United States by Age, Sex, Race, and Hispanic Origin: 1995-2050 1996, 25-1130. US Bureau of the Census, Current Population Reports, Washington, DC.
3. Nadpara P.A., Madhavan S.S., Tworek C., et al. Guideline-concordant lung cancer care and associated health outcomes among elderly patients in the United States. J. Geriatr. Oncol. 2015, 6:101-110.
4. Institute of Medicine Crossing The Quality Chasm: A New Health System for the 21st Century 2001, National Academy Press, Washington, DC.
5. Ensuring the Quality of Cancer Care 1999, National Academy Press, Washington, DC. M. Hewitt, J.V. Simone (Eds.).
6. BTS recommendations to respiratory physicians for organising the care of patients with lung cancer. The Lung Cancer Working Party of the British Thoracic Society Standards of Care Committee. Thorax 1998, 53(Suppl. 1):S1-S8.
7. Asch S.M., Kerr E.A., Hamilton E.G., Reifel J.L., McGlynn E.A. Quality of care for oncologic condition and HIV: a review of the literature and quality indicators. RAND 2000, 133-171.
8. Alberts W.M., Bepler G., Hazelton T., et al. Lung cancer. Practice organization. Chest 2003, 123:332S-337S.
9. Olsson J.K., Schultz E.M., Gould M.K. Timeliness of care in patients with lung cancer: a systematic review. Thorax 2009, 64:749-756.
10. Dransfield M.T., Lock B.J., Garver R.I. Improving the lung cancer resection rate in the US Department of Veterans Affairs Health System. Clin. Lung Cancer 2006, 7:268-272.
11. Gould M.K., Ghaus S.J., Olsson J.K., et al. Timeliness of care in veterans with non-small cell lung cancer. Chest 2008, 133:1167-1173.
12. Schultz E.M., Powell A.A., McMillan A., et al. Hospital characteristics associated with timeliness of care in veterans with lung cancer. Am. J. Respir. Crit. Care. Med. 2009, 179:595-600.
13. Seda G., Stafford C.M., Parrish J.S., et al. Population characterization, histological evaluation, and timeliness of care of surgical nonsmall cell lung cancer patients in a military academic medical center. Mil. Med. 2012, 177:748-751.
14. Kashiwabara K., Koshi S., Itonaga K., et al. Outcome in patients with lung cancer found on lung cancer mass screening roentgenograms, but who did not subsequently consult a doctor. Lung Cancer 2003, 40:67-72.
15. Kanashiki M., Satoh H., Ishikawa H., et al. Time from finding abnormality on mass-screening to final diagnosis of lung cancer. Oncol. Rep. 2003, 10:649-652.
16. Buccheri G., Ferrigno D. Lung cancer: clinical presentation and specialist referral time. Eur. Respir. J. 2004, 24:898-904.
17. Annakkaya A.N., Arbak P., Balbay O., et al. Effect of symptom-to-treatment interval on prognosis in lung cancer. Tumori 2007, 93:61-67.
18. Comber H., Cronin D.P., Deady S., et al. Delays in treatment in the cancer services: impact on cancer stage and survival. Ir. Med. J. 2005, 98:238-239.
19. Myrdal G., Lambe M., Hillerdal G., et al. Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax 2004, 59:45-49.
20. Neal R.D., Allgar V.L., Ali N., et al. Stage, survival and delays in lung, colorectal, prostate and ovarian cancer: comparison between diagnostic routes. Br. J. Gen. Pract. 2007, 57:212-219.
21. Yorio J.T., Xie Y., Yan J., et al. Lung cancer diagnostic and treatment intervals in the United States: a health care disparity?. J. Thorac. Oncol. 2009, 4:1322-1330.
22. Warren J.L., Klabunde C.N., Schrag D., et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med. Care 2002, 40. IV-3-18.
23. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 1997, 111:1710-1717.
24. Beckles M.A., Spiro S.G., Colice G.L., et al. Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest 2003, 123:97S-104S.
25. Agreement Between the SEER & Medicare Claims Regarding the Month of Diagnosis 2015, Available at: http://healthservices.cancer.gov/seermedicare/considerations/date.html (accessed 14.01.15).
26. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 1987, 40:373-383.
27. Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J. Clin. Epidemiol. 1992, 45:613-619.
28. Romano P.S., Roos L.L., Jollis J.G. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J. Clin. Epidemiol. 1993, 46:1075-1079.
29. Lin D.Y., Wei L.J. The robust inference for the Cox proportional hazards model. J. Am. Stat. Assoc. 1989, 84:1074-1078.
30. Bardell T., Belliveau P., Kong W., et al. Waiting times for cancer surgery in Ontario: 1984-2000. Clin. Oncol. (R. Coll. Radiol.) 2006, 18:401-409.
31. Simunovic M., Theriault M.E., Paszat L., et al. Using administrative databases to measure waiting times for patients undergoing major cancer surgery in Ontario, 1993-2000. Can. J. Surg. 2005, 48:137-142.
32. Campbell N.C., Elliott A.M., Sharp L., et al. Impact of deprivation and rural residence on treatment of colorectal and lung cancer. Br. J. Cancer 2002, 87:585-590.
33. Johnston G.M., MacGarvie V.L., Elliott D., et al. Radiotherapy wait times for patients with a diagnosis of invasive cancer, 1992-2000. Clin. Invest. Med. 2004, 27:142-156.
34. Potosky A.L., Riley G.F., Lubitz J.D., et al. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med. Care 1993, 31:732-748.